These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 32044365)

  • 1. Effect of Melatonin on Tau aggregation and Tau-mediated cell surface morphology.
    Das R; Balmik AA; Chinnathambi S
    Int J Biol Macromol; 2020 Jun; 152():30-39. PubMed ID: 32044365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melatonin Reduces GSK3β-Mediated Tau Phosphorylation, Enhances Nrf2 Nuclear Translocation and Anti-Inflammation.
    Das R; Balmik AA; Chinnathambi S
    ASN Neuro; 2020; 12():1759091420981204. PubMed ID: 33342257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melatonin interacts with repeat domain of Tau to mediate disaggregation of paired helical filaments.
    Balmik AA; Das R; Dangi A; Gorantla NV; Marelli UK; Chinnathambi S
    Biochim Biophys Acta Gen Subj; 2020 Mar; 1864(3):129467. PubMed ID: 31715192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Granular tau oligomers as intermediates of tau filaments.
    Maeda S; Sahara N; Saito Y; Murayama M; Yoshiike Y; Kim H; Miyasaka T; Murayama S; Ikai A; Takashima A
    Biochemistry; 2007 Mar; 46(12):3856-61. PubMed ID: 17338548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transition metal nickel prevents Tau aggregation in Alzheimer's disease.
    Gorantla NV; Das R; Balaraman E; Chinnathambi S
    Int J Biol Macromol; 2020 Aug; 156():1359-1365. PubMed ID: 31770557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The self-assembly ability of the first microtubule-binding repeat from tau and its modulation by phosphorylation.
    Zhou LX; Zeng ZY; Du JT; Zhao YF; Li YM
    Biochem Biophys Res Commun; 2006 Sep; 348(2):637-42. PubMed ID: 16889747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of tau oligomers in the onset of Alzheimer's disease neuropathology.
    Cárdenas-Aguayo Mdel C; Gómez-Virgilio L; DeRosa S; Meraz-Ríos MA
    ACS Chem Neurosci; 2014 Dec; 5(12):1178-91. PubMed ID: 25268947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro aggregation assays using hyperphosphorylated tau protein.
    Sui D; Liu M; Kuo MH
    J Vis Exp; 2015 Jan; (95):e51537. PubMed ID: 25590418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aggregation Kinetics and Filament Structure of a Tau Fragment Are Influenced by the Sulfation Pattern of the Cofactor Heparin.
    Townsend D; Fullwood NJ; Yates EA; Middleton DA
    Biochemistry; 2020 Oct; 59(41):4003-4014. PubMed ID: 32954725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of 14-3-3ζ with microtubule-associated protein tau within Alzheimer's disease neurofibrillary tangles.
    Qureshi HY; Li T; MacDonald R; Cho CM; Leclerc N; Paudel HK
    Biochemistry; 2013 Sep; 52(37):6445-55. PubMed ID: 23962087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photo-Excited Toluidine Blue Disaggregates the Repeat Tau and Modulates End-Binding Protein EB1, Cytoskeletal Structure in Neuronal Cells.
    Chinnathambi S; Dubey T; Chandrashekar M
    Cell Physiol Biochem; 2023 Apr; 57(2):123-136. PubMed ID: 37074918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of tau domain-specific antibodies and intravenous immunoglobulin on tau aggregation and aggregate degradation.
    Esteves-Villanueva JO; Trzeciakiewicz H; Loeffler DA; Martić S
    Biochemistry; 2015 Jan; 54(2):293-302. PubMed ID: 25545358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. O-GlcNAc modification of tau directly inhibits its aggregation without perturbing the conformational properties of tau monomers.
    Yuzwa SA; Cheung AH; Okon M; McIntosh LP; Vocadlo DJ
    J Mol Biol; 2014 Apr; 426(8):1736-52. PubMed ID: 24444746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-Faceted Role of Melatonin in Neuroprotection and Amelioration of Tau Aggregates in Alzheimer's Disease.
    Balmik AA; Chinnathambi S
    J Alzheimers Dis; 2018; 62(4):1481-1493. PubMed ID: 29562506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel drugs affecting tau behavior in the treatment of Alzheimer's disease and tauopathies.
    Navarrete LP; Pérez P; Morales I; Maccioni RB
    Curr Alzheimer Res; 2011 Sep; 8(6):678-85. PubMed ID: 21605038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tau (297-391) forms filaments that structurally mimic the core of paired helical filaments in Alzheimer's disease brain.
    Al-Hilaly YK; Foster BE; Biasetti L; Lutter L; Pollack SJ; Rickard JE; Storey JMD; Harrington CR; Xue WF; Wischik CM; Serpell LC
    FEBS Lett; 2020 Mar; 594(5):944-950. PubMed ID: 31721178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structurally Distinct Polymorphs of Tau Aggregates Revealed by Nanoscale Infrared Spectroscopy.
    Banerjee S; Ghosh A
    J Phys Chem Lett; 2021 Nov; 12(45):11035-11041. PubMed ID: 34747175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fisetin inhibits tau aggregation by interacting with the protein and preventing the formation of β-strands.
    Xiao S; Lu Y; Wu Q; Yang J; Chen J; Zhong S; Eliezer D; Tan Q; Wu C
    Int J Biol Macromol; 2021 May; 178():381-393. PubMed ID: 33662414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Azure C Targets and Modulates Toxic Tau Oligomers.
    Lo Cascio F; Kayed R
    ACS Chem Neurosci; 2018 Jun; 9(6):1317-1326. PubMed ID: 29378132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cobalt-based metal complexes prevent Repeat Tau aggregation and nontoxic to neuronal cells.
    Gorantla NV; Balaraman E; Chinnathambi S
    Int J Biol Macromol; 2020 Jun; 152():171-179. PubMed ID: 32105696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.